Clinical Trials Logo

Clinical Trial Summary

Lupus disease is characterized by the production of pathogenic autoantibodies, which participate in end-organ damages. The phenotype of B cells producing the pathogenic autoantibodies in lupus patients is today unknown. Antinucleosome antibodies are characteristic of lupus disease.This project proposes to detect antinucleosome B cells in lupus patients and to analyse their phenotype and their frequency.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01889654
Study type Observational
Source University Hospital, Strasbourg, France
Contact
Status Terminated
Phase N/A
Start date February 2014
Completion date July 2015